UNIVERSITY OF WASHINGTON

Their core work

The University of Washington is a major US research university contributing specialized expertise to European research consortia across a remarkably broad range of disciplines — from respiratory health and infectious disease to condensed matter physics, protein engineering, and environmental science. Their H2020 involvement is almost entirely as a third-party or partner institution, providing access to world-class facilities and deep domain knowledge that European-led projects cannot easily source within the EU. UW's contributions span computational modeling, advanced materials characterization, biological design, and clinical research, reflecting the university's strength as a multidisciplinary research powerhouse based in Seattle.

What they specialise in

How they've shifted over time

In the early period (2015–2018), UW's H2020 work concentrated on atmospheric chemistry, respiratory health, perovskite solar cells, and evolutionary biology — reflecting traditional strengths in public health and environmental science. From 2019 onward, a clear shift emerged toward computational design and engineered biology: protein engineering, metamaterials, in silico modeling, and data-driven structural optimization became prominent. The portfolio also expanded into quantum physics (NONLOCAL) and cognitive neuroscience, suggesting deliberate diversification beyond their original environmental and health focus.

UW is moving toward computationally intensive, design-driven research — protein engineering, metamaterial optimization, and quantum systems — making them an increasingly valuable partner for projects needing advanced simulation and biological design capabilities.

How they like to work

UW never coordinates H2020 projects — all 25 participations are as partner or third party, with 19 of 25 as third-party contributions. This is typical for a non-EU institution: they provide specialized expertise and infrastructure rather than administrative leadership. With 201 unique consortium partners across 39 countries, they are a highly networked but non-leading contributor, easy to integrate into large consortia without competing for coordination roles.

UW has collaborated with 201 unique partners across 39 countries, giving them one of the broadest international networks of any non-EU H2020 participant. Their connections span virtually all of Europe plus global partnerships, reflecting the university's reputation as a go-to third-country expert.

What sets them apart

As a top US research university participating in EU framework programs, UW offers something few European partners can: access to American research infrastructure, faculty networks, and complementary funding ecosystems without competing for coordination. Their extraordinary breadth — spanning quantum physics, protein design, climate science, and cognitive neuroscience — means they can contribute meaningfully to almost any technically ambitious consortium. For European coordinators, partnering with UW signals international credibility and opens doors to transatlantic research networks.

Highlights from their portfolio

• NONLOCAL
  By far UW's largest H2020 funding (EUR 1.9M) — an ERC-linked project on Majorana fermions and topological quantum states, running until 2027.
• Trep-AB
  Addresses a neglected disease (syphilis) with drug repurposing and whole genome sequencing — a rare intersection of infectious disease genomics and clinical trials.
• DecisionES
  Long-running project (2021–2026) on decision support for ecosystem services under global change, combining forest management, fire risk, and adaptive planning.